君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02511 君圣泰医药-B

收市竞价 12-23 16:04:33

1.280

+0.140

+12.28%

最高1.360	最低1.100	成交量232.00万
今开1.100	昨收1.140	日振幅22.81%
总市值6.59亿	流通市值6.59亿	总股本5.15亿
成交额299.28万	换手率0.45%	流通股本5.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02511","market":"HK","secType":"STK","nameCN":"君圣泰医药-B","latestPrice":1.28,"timestamp":1734940990394,"preClose":1.14,"halted":0,"volume":2320000,"delay":0,"floatShares":514770668,"shares":514770668,"eps":-3.8430824,"marketStatus":"收市竞价","marketStatusCode":4,"change":0.14,"latestTime":"12-23 16:04:33","open":1.1,"high":1.36,"low":1.1,"amount":2992830,"amplitude":0.22807,"askPrice":1.28,"askSize":86500,"bidPrice":1.28,"bidSize":15000,"shortable":0,"etf":0,"ttmEps":-1.7806589184705754,"exchange":"SEHK","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734941400000},"adr":0,"listingDate":1703174400000,"adjPreClose":1.14,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":3.268526,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02511/wiki","defaultTab":"wiki","newsList":[{"id":"2493208928","title":"君圣泰医药-B盘中异动 早盘快速拉升6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493208928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493208928?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:48","pubTimestamp":1734918511,"startTime":"0","endTime":"0","summary":"2024年12月23日早盘09时48分，君圣泰医药-B股票出现异动，股价大幅拉升6.14%。君圣泰医药-B股票所在的药品行业中，整体涨幅为0.03%。其相关个股中，华控康泰、海王英特龙、君圣泰医药-B涨幅较大，振幅较大的相关个股有草姬集团、君圣泰医药-B、海王英特龙，振幅分别为9.06%、8.77%、8.13%。君圣泰医药-B公司简介：君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223094831984d2734&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223094831984d2734&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2492456394","title":"君圣泰医药-B盘中异动 早盘股价大涨5.61%报1.130港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492456394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492456394?lang=zh_cn&edition=full","pubTime":"2024-12-20 10:29","pubTimestamp":1734661796,"startTime":"0","endTime":"0","summary":"2024年12月20日早盘10时29分，君圣泰医药-B股票出现异动，股价快速上涨5.61%。截至发稿，该股报1.130港元/股，成交量18.9万股，换手率0.04%，振幅8.41%。资金方面，该股资金流入12.0915万港元，流出6.728万港元。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.04%。消息层面，截至10时29分，《君圣泰医药-B：与石四药集团订立战略合作框架协议》资讯为影响君圣泰医药-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220102956a1fc885c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220102956a1fc885c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2492543211","title":"金十数据整理：每日港股市场要闻速递（12月20日 周五）","url":"https://stock-news.laohu8.com/highlight/detail?id=2492543211","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492543211?lang=zh_cn&edition=full","pubTime":"2024-12-20 08:59","pubTimestamp":1734656375,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0029875118.USD","ZFmain","159837","SG9999000327.SGD","002352","00999","TNmain","EUO","LU1196710864.SGD","03968","03143","UBmain","MEURmain","01398","ZBmain","02359","ZNmain","02598","FXE","IE00BZ1G4Q59.USD","TCEHY","LU2045819591.USD","YANG","ETH","601398","HTCD.SI","600036","02696","LU0128522744.USD","06936","EURmain","HSCEI","80700","LU0106252389.USD","00700","603259","LU1720050803.USD","ZTmain","LU0149721374.USD","SG9999001903.USD","LU1688375341.USD","LU2362541513.USD","02005","07226","HSTECH","LU0163747925.USD","LU0882574139.USD","02511","LU2237443895.HKD"],"gpt_icon":0},{"id":"2492434687","title":"【湾区早参】澳门11月综合消费物价指数按年上升0.3%；深圳外贸首次突破4万亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492434687","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492434687?lang=zh_cn&edition=full","pubTime":"2024-12-20 08:31","pubTimestamp":1734654707,"startTime":"0","endTime":"0","summary":"据悉，这是深圳外贸历史性突破，也是深圳外贸进出口规模首次迈上4万亿元台阶。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/NGVhNjVkZTQ2ODU4ZWQyYjc4YjcyMmRkNWUzMjAzNTczNzI1NTIy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGVhNjVkZTQ2ODU4ZWQyYjc4YjcyMmRkNWUzMjAzNTczNzI1NTIy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1950002","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1169","01665","BK1507","LU0823426480.USD","LU1224709979.USD","TNmain","BK1560","BK1231","BK1521","BK1240","LU0359201885.HKD","BK1564","01398","LU0737861699.HKD","02511","BK1147","02005","ZBmain","LU1880383366.USD","LU2460026573.USD","LU1023057109.AUD","LU1880383440.USD","ZFmain","LU0823426308.USD","BK1601","UBmain","LU0287142896.SGD","BK1582","00127","LU0359202008.SGD","BK1216","BK1219","ZNmain","LU0173614495.USD","06881","ZTmain","09860","03143","IE0032431581.USD","01638","BK1555","LU0359201612.USD","BK1191"],"gpt_icon":0},{"id":"2492431520","title":"君圣泰医药-B公布高丽萍已获委任为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2492431520","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492431520?lang=zh_cn&edition=full","pubTime":"2024-12-20 08:12","pubTimestamp":1734653520,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　君圣泰医药-B（02511）发布公告，由于需投放更多时间于其他工作安排，于莉已提呈辞任公司的联席公司秘书，自2024年12月19日起生效。于莉于辞任联席公司秘书后，将留任集团副总裁及深圳君圣泰生物技术有限公司（公司的全资附属公司）副总经理。\n　　高丽萍已获委任为联席公司秘书，自2024年12月19日起生效，彼将与朱璧敏（现为公司另一名联席公司秘书）共同履行公司秘书的职责。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-20/doc-ineaaewz9394718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2492179118","title":"君圣泰医药-B(02511)：高丽萍已获委任为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2492179118","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492179118?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:34","pubTimestamp":1734618855,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君圣泰医药-B(02511)发布公告，由于需投放更多时间于其他工作安排，于莉已提呈辞任公司的联席公司秘书，自2024年12月19日起生效。于莉于辞任联席公司秘书后，将留任集团副总裁及深圳君圣泰生物技术有限公司(公司的全资附属公司)副总经理。高丽萍已获委任为联席公司秘书，自2024年12月19日起生效，彼将与朱璧敏(现为公司另一名联席公司秘书)共同履行公司秘书的职责。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2492141674","title":"石四药集团：与君圣泰医药就共同研发订立框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492141674","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492141674?lang=zh_cn&edition=full","pubTime":"2024-12-19 17:27","pubTimestamp":1734600463,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1161","02005","LU2460026573.USD","02511","BK1191"],"gpt_icon":0},{"id":"2492149486","title":"君圣泰医药-B(02511)附属与石家庄四药订立战略合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492149486","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492149486?lang=zh_cn&edition=full","pubTime":"2024-12-19 17:17","pubTimestamp":1734599841,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君圣泰医药-B 发布公告，集团的全资附属公司已与石四药集团有限公司的全资附属公司石家庄四药有限公司，订立一份战略合作框架协议，旨在结合集团在天然产物多系统协同创新领域的独特优势及石四药集团在活性筛选、制剂开发、成果转化、质量及成本控制等方面的丰富经验，共同攻克行业难点，为全球代谢慢病、长寿抗衰等领域提供突破性解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227081.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2492914106","title":"君圣泰医药-B：与石四药集团订立战略合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492914106","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492914106?lang=zh_cn&edition=full","pubTime":"2024-12-19 17:16","pubTimestamp":1734599777,"startTime":"0","endTime":"0","summary":"格隆汇12月19日丨君圣泰医药-B公布，集团的全资附属公司已与石四药集团有限公司的全资附属公司石家庄四药有限公司，订立一份战略合作框架协议，旨在结合集团在天然产物多系统协同创新领域的独特优势及石四药集团在活性筛选、制剂开发、成果转化、质量及成本控制等方面的丰富经验，共同攻克行业难点，为全球代谢慢病、长寿抗衰等领域提供突破性解决方案。石家庄四药为石四药集团的全资附属公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219173213a1facea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219173213a1facea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","LU2460026573.USD","02511","02005","BK1161"],"gpt_icon":0},{"id":"2492146483","title":"石四药集团与君圣泰医药达成战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492146483","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492146483?lang=zh_cn&edition=full","pubTime":"2024-12-19 16:53","pubTimestamp":1734598437,"startTime":"0","endTime":"0","summary":"财中社12月19日电石四药集团（02005）发布公告，宣布其全资附属公司石家庄四药有限公司已与君圣泰医药的全资附属公司签订了一份战略合作框架协议。该协议旨在结合公司在活性筛选、制剂开发等方面的经验与君圣泰医药在天然产品多系统协同创新领域的优势，共同研发全球代谢慢病和长寿抗衰等领域的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412193273341046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","LU2460026573.USD","02005","02511","BK1191"],"gpt_icon":0},{"id":"2492145981","title":"石四药集团(02005)与君圣泰医药就共同研发订立框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492145981","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492145981?lang=zh_cn&edition=full","pubTime":"2024-12-19 16:36","pubTimestamp":1734597410,"startTime":"0","endTime":"0","summary":"根据框架协议并按照其中的条款及条件，集团与君圣泰医药(双方)利用各自优势，为全球代谢慢病、长寿抗衰等领域共同研发并实现合作项目的成果转化、报批上市及市场推广等全链条工作，包括建立联合研究中心、研发创新产品、打造行业生态，及进行市场推广和商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1161","02005","02511","LU2460026573.USD"],"gpt_icon":0},{"id":"2492145783","title":"石四药集团(02005.HK)附属与君圣泰医药-B(02511.HK)子公司订立框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492145783","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492145783?lang=zh_cn&edition=full","pubTime":"2024-12-19 16:35","pubTimestamp":1734597300,"startTime":"0","endTime":"0","summary":"石四药集团公布，其子公司石家庄四药与君圣泰医药-B子公司订立一份战略合作框架协议，旨在结合集团在活性筛选、制剂开发、成果转化、质量及成本控制等方面的丰富经验以及君圣泰医药在天然产物多系统协同创新领域的独特优势，为全球代谢慢病、长寿抗衰等领域提供突破性解决方案。沽空资料截至 2024-12-19 16:25。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230207105255269_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230207105255269_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405299/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02005","LU2460026573.USD","BK1191","02511"],"gpt_icon":0},{"id":"2492111537","title":"君圣泰医药－Ｂ(02511)股价大幅上升17.526%，现价港币$1.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2492111537","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492111537?lang=zh_cn&edition=full","pubTime":"2024-12-19 13:15","pubTimestamp":1734585300,"startTime":"0","endTime":"0","summary":"[上升股]君圣泰医药－Ｂ(02511) 股价在下午01:15比前收市价大幅上升17.526%，现股价为港币$1.14。至目前为止，今日最高价为$1.14，而最低价为$0.97。总成交量为56.6万股，总成交金额为港币$56.933万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241219888/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2492607113","title":"君圣泰医药-B盘中异动 下午盘快速拉升6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492607113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492607113?lang=zh_cn&edition=full","pubTime":"2024-12-19 13:01","pubTimestamp":1734584470,"startTime":"0","endTime":"0","summary":"2024年12月19日下午盘13时01分，君圣泰医药-B股票出现波动，股价快速上涨6.19%。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.13%。其相关个股中，草姬集团、励晶太平洋、君圣泰医药-B涨幅较大，振幅较大的相关个股有草姬集团、励晶太平洋、开拓药业-B，振幅分别为21.60%、10.61%、8.82%。君圣泰医药-B公司简介：君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219130110a1fa494d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219130110a1fa494d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2492019677","title":"君圣泰医药-B盘中异动 早盘股价大跌6.25%报0.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492019677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492019677?lang=zh_cn&edition=full","pubTime":"2024-12-17 10:01","pubTimestamp":1734400880,"startTime":"0","endTime":"0","summary":"2024年12月17日早盘10时01分，君圣泰医药-B股票出现波动，股价快速下跌6.25%。截至发稿，该股报0.900港元/股，成交量1.8万股，换手率0.00%，振幅9.37%。资金方面，该股资金流入1425港元，流出1.51万港元。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.04%。其相关个股中，联康生物科技集团、李氏大药厂、雅各臣科研制药涨幅较大，振幅较大的相关个股有李氏大药厂、精优药业、联康生物科技集团，振幅分别为7.86%、7.27%、6.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217100120ab7dd1e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217100120ab7dd1e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2490891849","title":"君圣泰医药(02511.HK)更换核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2490891849","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490891849?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:36","pubTimestamp":1733967360,"startTime":"0","endTime":"0","summary":"君圣泰医药(02511.HK) 公布，安永已辞任核数师，自昨日(11日)起生效，原因为双方未能就截至今年12月底止年度的建议审计费用达成协议。同时，公司委任香港大华马施云为新任核数师，预期将任职至公司应届股东周年大会结束为止。(jl/k)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240109103805072_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240109103805072_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1403578/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2490374478","title":"君圣泰医药-B(02511)委任大华马施云为新任核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2490374478","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490374478?lang=zh_cn&edition=full","pubTime":"2024-12-11 19:10","pubTimestamp":1733915449,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君圣泰医药-B(02511)发布公告，安永会计师事务所已辞任公司核数师，自2024年12月11日起生效。经审核委员会作出推荐建议，已决议委任大华马施云会计师事务所有限公司为公司新任核数师，自2024年12月11日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1223680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2488900229","title":"君圣泰医药-B盘中异动 早盘股价大跌6.73%报0.970港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488900229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488900229?lang=zh_cn&edition=full","pubTime":"2024-12-04 09:39","pubTimestamp":1733276376,"startTime":"0","endTime":"0","summary":"2024年12月04日早盘09时39分，君圣泰医药-B股票出现异动，股价急速下挫6.73%。截至发稿，该股报0.970港元/股，成交量3.8万股，换手率0.01%，振幅0.00%。资金方面，该股资金流入0港元，流出3.686万港元。君圣泰医药-B股票所在的药品行业中，整体涨幅为0.03%。其相关个股中，东阳光长江药业、中生联合、联康生物科技集团涨幅较大，振幅较大的相关个股有信达生物、丽珠医药、绿叶制药，振幅分别为3.03%、2.62%、2.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204093936a26ac85f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204093936a26ac85f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2488978964","title":"君圣泰医药-B盘中异动 大幅拉升7.22%报1.040港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488978964","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488978964?lang=zh_cn&edition=full","pubTime":"2024-12-03 15:45","pubTimestamp":1733211951,"startTime":"0","endTime":"0","summary":"2024年12月03日临近收盘15时45分，君圣泰医药-B股票出现异动，股价快速上涨7.22%。资金方面，该股资金流入12.9075万港元，流出10.3015万港元。君圣泰医药-B股票所在的药品行业中，整体涨幅为0.06%。君圣泰医药-B公司简介：君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203154551abf21459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203154551abf21459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2488796220","title":"君圣泰医药－Ｂ(02511)股价上升7.216%，现价港币$1.04","url":"https://stock-news.laohu8.com/highlight/detail?id=2488796220","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488796220?lang=zh_cn&edition=full","pubTime":"2024-12-03 15:45","pubTimestamp":1733211900,"startTime":"0","endTime":"0","summary":"[上升股]君圣泰医药－Ｂ(02511) 股价在下午03:45比前收市价上升7.216%，现股价为港币$1.04。至目前为止，今日最高价为$1.04，而最低价为$0.93。总成交量为24.9万股，总成交金额为港币$23.93万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2412031881/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02511","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hightidetx.com","stockEarnings":[{"period":"1week","weight":0.1875},{"period":"1month","weight":0.0962},{"period":"3month","weight":0.2809},{"period":"6month","weight":-0.6825},{"period":"1year","weight":-0.9009},{"period":"ytd","weight":-0.912}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"HighTide Therapeutics Inc是一家主要从事原研药生产的公司。该公司专注于代谢疾病、消化系统疾病等领域。该公司开发针对非酒精性脂肪性肝炎（NASH）、2型糖尿病（T2DM）、严重高甘油三酯血症（SHTG）、原发性硬化性胆管炎（PSC）和原发性胆汁性胆管炎（PBC）等适应症的治疗方法。","exchange":"SEHK","name":"君圣泰医药-B","nameEN":"HIGHTIDE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君圣泰医药-B,02511,君圣泰医药-B股票,君圣泰医药-B股票老虎,君圣泰医药-B股票老虎国际,君圣泰医药-B行情,君圣泰医药-B股票行情,君圣泰医药-B股价,君圣泰医药-B股市,君圣泰医药-B股票价格,君圣泰医药-B股票交易,君圣泰医药-B股票购买,君圣泰医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}